Western University

Scholarship@Western
Digitized Theses

Digitized Special Collections

2011

High-Intensity Interval Training Speeds O2 Uptake Kinetics in
Moderate-Intensity Exercise Transitions Initiated from Low and
Elevated Metabolic Baselines
Alexandra Mackenzie Williams

Follow this and additional works at: https://ir.lib.uwo.ca/digitizedtheses

Recommended Citation
Williams, Alexandra Mackenzie, "High-Intensity Interval Training Speeds O2 Uptake Kinetics in ModerateIntensity Exercise Transitions Initiated from Low and Elevated Metabolic Baselines" (2011). Digitized
Theses. 3389.
https://ir.lib.uwo.ca/digitizedtheses/3389

This Thesis is brought to you for free and open access by the Digitized Special Collections at
Scholarship@Western. It has been accepted for inclusion in Digitized Theses by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

High-Intensity Interval Training Speeds O2 Uptake Kinetics in
Moderate-Intensity Exercise Transitions Initiated from
Low and Elevated Metabolic Baselines

(Spine title: HIT Speeds VO2 Kinetics in Moderate Intensity Exercise)
(Thesis format: Integrated Article)

by

Alexandra M. Williams

Graduate Program in Kinesiology

A thesis submitted in partial fulfillment
of the requirements for the degree of
Master of Science

The School of Graduate and Postdoctoral Studies
The University of Western Ontario
London, Ontario, Canada

© Alexandra M. Williams
September 2011

THE UNIVERSITY OF WESTERN ONTARIO
School of Graduate and Postdoctoral Studies

CERTIFICATE OF EXAMINATION

Supervisor

Examiners

Dr. John M. Kowalchuk

Dr. Peter Lemon

Supervisory Committee

Dr. Greg Marsh

Dr. Donald H. Paterson

Dr. Christopher G. Ellis

The thesis by

Alexandra Mackenzie Williams
entitled:

High-Intensity Interval Training Speeds O2 Uptake Kinetics in
Moderate-Intensity Exercise Transitions Initiated from
Low and Elevated Metabolic Baselines
is accepted in partial fulfillment of the
requirements for the degree of
Master of Science

Date
Chair of the Thesis Examination Board

Abstract
The purpose of this study was to investigate the effects high-intensity interval training
(HIT) on V 0 2p kinetics during transitions from low and elevated metabolic rates,
within the moderate-intensity (MOD) domain. Eight untrained males completed 12
sessions of HIT, consisting of 8-12 intervals cycling at 110% maximal O2 uptake
(V 02P) on a cycle ergometer. Ramp incremental, performance, and double-step
constant-load tests were completed at 4 time points throughout training. HIT led to
increases in V02max fP<0.05) and performance (PO.Ol). Additionally,

t V02P

of

both lower and upper MOD step transitions were reduced by -40% (LS: 24s—►15s;
US: 45s—►25s) (PO .Ol). The time course of muscle deoxygenation was not changed
with HIT, suggesting improved matching of microvascular O2 delivery with muscle
O2 utilization. These results are the first to demonstrate speeding of both lower and
upper step MOD V 0 2 P kinetics following an effective HIT program, with significant
simultaneous improvements in both performance and V 0 2 max.

Key Words: O2 uptake kinetics, high-intensity interval training, near-infrared
spectroscopy (NIRS), O2 deficit, exercise performance
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Chapter 1:

Review of the Literature
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1.1 Introduction
At the onset of exercise transitions from rest or light-intensity exercise, there
is an immediate increase in the demand for energy in the active muscle sites; the
energy supplied by oxidative phosphorylation rises slowly in response to the
increased demands, necessitating a relatively larger contribution of substrate-level
phosphorylation (intramuscular degradation of phosphocreatine (PCr), glycogen
catabolism, and accumulation of lactate) to meet the bulk of the additional energy
requirement (31, 57). Thus, while ATP turnover increases instantaneously during
step-increases in work rate, the observed increases in both muscle oxygen (O2) uptake
(V 0 2m) and pulmonary oxygen (0 2) uptake (VCbp) are relatively slow (27). In the
moderate-intensity (MOD) domain (i.e., work rates below lactate threshold (0l)),
V 0 2 p rises exponentially with time, as oxidative phosphorylation progressively
makes a larger contribution to ATP resynthesis, until a new steady-state is reached;
the steady-state is accomplished when the total energy requirements are derived from
atmospheric 0 2 (55, 59). In MOD exercise, VChp will often reach the new SS within
two to three minutes. In heavy- or severe-intensity exercise (above 0l), the steadystate is either delayed or is not attained at all.
Several methods may be used to assess changes in V 0 2m. In animals (5, 6,
29), as well as human subjects (19, 30, 33), a close approximation of V 0 2m may be
determined by measuring the arteriovenous 0 2 content difference across the area or
muscle of interest. Another method involves 31P-nuclear magnetic resonance
spectroscopy; as the kinetics of PCr degradation have been found to mirror those of
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V 0 2 P at the onset of exercise, the measurement of changes in human muscle [PCr]
has been used to estimate changes in muscle VO2 (3, 28, 50, 51, 56, 57). More
commonly, however, the estimation of muscle VO2 has been established through the
measurement of pulmonary O2 uptake ( V02P). This technique is minimally invasive,
and has been shown to accurately reflect muscle VO2 within 10% (19, 50).
The overall V02P profile of a response to square-wave transitions in work rate
depends on the intensity domain of the exercise being performed. In the MOD
domain of exercise, the adaptation of V 0 2 P may be characterized by a multi-phase
exponential increase (see Figure I). Phase I, termed the “cardiodynamic” phase of gas
exchange, reflects the immediate increase in cardiac output (heart rate and stroke
volume) and pulmonary blood flow at the onset of the exercise transition. This period
of time reflects a delay in tissue-to-lung vascular transit, and thus does not yet reflect
alterations in V02m (4, 35, 58). The subsequent “fundamental” phase II response
involves a mono-exponential increase in VC>2P due to the arrival of deoxygenated
blood (from the active muscle) to the pulmonary circulation. This phase closely
reflects the increases in O2 extraction supporting the increased energy demands of the
working muscle (4, 13, 19, 57, 59). Finally, phase III describes the attained steadystate V 0 2 P for the given increase in work rate.
The overall adaptation of V02P following a MOD exercise transition is
described by the kinetics of the fundamental phase II response. Specifically, the
exponential increase in V 0 2 P may be described by a time constant (x), which reflects
the time required to reach 63% of the steady-state response (86%, 95%, and 98% of
the response are achieved after 2x, 3x, and 4x, respectively). The response may also be
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characterized by its overall amplitude: the change in V 0 2 P from a baseline steadystate to a newly-attained steady-state following the exercise transition. Knowledge of
the amplitude and the time constant allow for the estimation of the O2 deficit, which
reflects the relative reliance on non-oxidative pathways (i.e., PCr and glycogen
breakdown) for energy production during exercise transitions (13, 15, 44).
1.2 Factors Limiting Oxygen Uptake Kinetics
A number of factors have been suggested to control or limit O2 uptake kinetics
(x VO 2) following the onset of exercise; debate has existed surrounding the influence
of two proposed factors on TVO2, i) “sluggish” adjustment of intracellular
metabolism to the increased metabolic demand (“metabolic inertia”) and ii) limitation
of O2 delivery to the active muscle sites (18, 53, 54).
Alterations in arterial O2 content have been used to investigate the proposed
limitation of O2 delivery to iVChp. The application of a hypoxic condition (i.e., 1014% inspired O2) has been consistently shown to slow VChp kinetics in upright
cycling exercise (36, 42). Hyperoxia (> 60% inspired O2), however, has been shown
to speed VÜ 2P kinetics, but only when transitions occur in the heavy-intensity
domain, with no effect on x VC>2P in MOD domain exercise transitions (25, 37). These
data suggest that a limitation in O2 transport may restrict V 0 2 P kinetics at exercise
intensities above the 0 l, but not below it. Additionally, both ß-adrenergic receptor
blockade (impairing adaptations of cardiac output) and supine exercise conditions
(reducing arterial perfusion pressures) have been shown to slow VÜ 2P kinetics;
however, V 0 2 P kinetics are sped to match those of “normal” upright cycling when
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lower body negative pressure is applied during supine cycling exercise (22-24, 38).
Collectively, these observations suggest that an O2 transport limitation does not limit
V 0 2p kinetics for MOD exercise in “normal” conditions (i.e., upright exercise, in
normoxia). It should be noted that an 0 2 transport limitation may play a role in other
common conditions, such as exercise at altitude (53).
Several other observations lend support to the hypothesized “metabolic
inertia” in limiting VC>2P kinetics, rather than limitations in 0 2 transport. The kinetics
of cardiovascular dynamics have been consistently observed to be faster than those of
V 0 2p (14); it is unlikely that faster-adapting cardiovascular parameters limit the
relatively slower-adapting V 0 2m. Next, the observed similarities of profiles for both
[PCr] and V 0 2 P kinetics suggest a role for phosphate-linked processes in the control
of t VC>2P (50). Much focus has also been placed on the potential role of pyruvate
dehydrogenase (PDH) in limiting

VC>2P kinetics. Following an infusion of

diochloroacetate (DCA, increases active form of PDH) in single muscle fibres,
Howlett et al. (21) observed increases in substrate provision (acetylcamitine and
acetyl-CoA) and decreases in PCr degradation, resulting in an overall increase in
oxidative metabolism during rest-to-work transitions. Similarly, Gurd et al. (20)
observed reductions in xV02P in MOD exercise when PDH activation was elevated
prior to the on-transition.
A recent proposed model has integrated and applied the two hypotheses across
varying exercise conditions: the “tipping point”, proposed by Poole and colleagues
(46, 47), explains that below a certain ‘point’ or rate of muscle 0 2 delivery, an 0 2
limitation will occur and progressively slow VC>2P kinetics. However, above or
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beyond the tipping point, xVOip will be most sensitive to metabolic ‘sluggishness’,
and will not be significantly altered by modest changes in O2 delivery.
Contrasts between groups of differing training status and age provide further
insight to the potential mechanisms limiting VChp kinetics. Cross-sectional studies
have indentified variations in x VChp in relation to training status, maximal O2 uptake
(VC>2max), and age (young vs older adults) (1, 12, 48). While older adults have
traditionally been observed to have significantly slowed VChp kinetics compared to
those of younger adults, Murias et al. (41) have recently demonstrated a spectrum of
values for xVChp in young adults alone. Among 37 young males, iVChp has been
found to vary from very fast (<21 s) to slow (>40s). Where x VChp is larger than ~20
s, the adaptation of O2 uptake appears to be mainly constrained by the matching of
local microvascular O2 distribution to muscle O2 utilization.
Overall, it seems that an interplay of both O2 delivery and intrinsic metabolic
inertia determine the adaptation of V02P to step-increases in work rate. The relative
contribution of either factor likely depends on the exercise condition, as well as the
exercising individual (i.e., training status, health etc.). Additionally, the specific
matching of microvascular O2 distribution to the O2 requirements of the exercising
muscle appears to play a key role in determining xV 0 2 P, even among individuals of
similar age and health status.
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1.3 Altered Oxygen Uptake Kinetics in Transitions from Elevated
M etabolic Rates
In 1982, Hughson and Morrissey (26) identified slowed VChp kinetics in transitions
from prior MOD exercise; these observations were the first to demonstrate non-linear
behavior in the V02P system. Later, Brittain et al. (9) developed a double-step
constant-load MOD intensity cycling exercise test (see Figure II); the lower step (LS)
was a transition from 20 W to A50 (corresponding to a work rate 50% between 20 W
and 90% of the estimated 0L ( 0 l )), and the latter upper step (US) involved a
A

transition from A50 to 90%

0l

. While the LS and US consisted of similar increases

in work rate, the US xV 0 2 P was larger than that of the LS. Consistent with the
observations of Hughson and Morrissey (26), these results did not support the
dynamic linearity system model for VC)2P in the MOD domain. Along with the
slowed adjustment of V 0 2 P, the US also had a greater gain in V02P per unit increase
in power output. It was suggested that the observed slowing of V02P kinetics in the
upper region of the MOD domain of exercise may be due to the orderly recruitment
of motor units, where those recruited in the US were less “efficient” oxidative muscle
fibres (i.e., lesser mitochondrial content and slower x[PCr]).
Further investigations using the double-step constant-load MOD exercise test
have additionally described slowing of femoral artery blood flow kinetics, heart rate
(HR) kinetics, and muscle deoxygenation [HHb] kinetics in the US (39). It was
suggested that the slowing of MOD upper region V02P kinetics resulted, in part,
from a limitation in bulk blood flow and O2 transport; however, a role for intrinsic
metabolic inertia could not be ruled out as a potential limiting factor.
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Slowed US VChp kinetics have also been observed in the heavy-intensity
domain (16), as well as for older adults in the MOD domain (52). While the specific
physiological factors contributing to a larger US xVOzp remain elusive, compelling
new evidence from Bowen et al. (8) offer further insight to the potential mechanisms
involved. In addition to the Brittain double-step protocol (9), this investigation
employed an exercise test entailing an initial step from 20 W to 90%

0l

, followed by

30 s rest, and a subsequent, immediate step-increase in work rate back to 90%

0l .

This test allowed for the dissociation of a raised work rate from a raised metabolic
rate. Following a rise in metabolic rate, kinetics were slowed similarly to those in the
US of the original double-step test even when initiated from ‘unloaded’ cycling,
demonstrating that slowed kinetics in the upper region of the MOD domain could not
be explained by the influences of pre-transition work rate, muscle oxygenation or
circulatory dynamics.
1.4 Effect o f H igh-Intensity Interval Training on Oxygen Uptake
Kinetics
While the effects of endurance (END) training on V02P kinetics have been
frequently examined, very few studies have investigated the effects of high-intensity
interval training (HIT) or sprint-interval training (SIT) on V02P kinetics (2, 7, 32, 40,
43). HIT, involving repeated intervals of heavy-intensity exercise (often above 100%
V02max) separated by short periods of rest, has been found to shorten x VChp during
single step-transitions in the MOD domain; it has been suggested that these
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improvements occur due to increases in glycolytic capacity (34), bulk O2 delivery to
the working muscle and/or activities of key muscle metabolic enzymes (7).
Recently, McKay et al. (40) observed the effects of 8 sessions of HIT on VChp
kinetics in young, untrained men. Following the training programme, they observed
an overall reduction of xV02P by ~40%; notably, about half of the total change in
xVChp was accomplished within only two sessions of HIT. These alterations in VChp
kinetics occurred without any accompanying changes in the adaptation of muscle
deoxygenation [HHb], suggesting that HIT led to an improved “matching” of local
microvascular blood flow to O2 utilization. It was postulated that changes in muscle
metabolic properties contributed to the overall speeding of VChp kinetics. Training
has been shown to upregulate the activity of PDH; an increased activation of PDH
would allow for greater substrate provision to the tricarboxylic acid (TCA) cycle and
electron transport chain (ETC) early in the transition to MOD exercise (11, 20, 49).
Consequently, potential elevations in the production or sensitivity of PDH regulators
following training may have contributed to the reductions in xVChp. Increases in
cytochrome-C oxidase subunit 4 (COX4, a marker of oxidative capacity) have also
been frequently observed following short-term HIT and SIT training programmes (10,
17, 45); increases in COX4 would allow for increased flux through the ETC, thus
potentially contributing to the training-induced speeding of VChp kinetics. Clearly,
HIT has the potential to induce metabolic adaptations at the level of the muscle, and
these adaptations have been found to collectively reduce xVChp during single steptransitions to MOD intensity exercise; however, the effects of HIT on V02P kinetics
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in transitions from elevated metabolic rates (i.e., in a double-step, constant load
model adapted from Brittain et al. (9)) have not yet been investigated.
The primary purpose of this study was to examine the effects of a HIT training
programme on V 0 2 P kinetics during transitions from low and elevated baseline
metabolic rates, within the MOD domain of exercise. The HIT training programme
was adapted from that of McKay et al. (40), and we observed the time course of
adaptation of both V02P kinetics and muscle deoxygenation ([HHb], measured with
near-infrared spectroscopy) over 12 sessions of HIT. The following hypotheses were
tested 1) in transitions to MOD exercise, both V02P and [HHb] kinetics would be
slower when exercise was initiated from a high (upper step; US) compared to a low
(lower step; LS) baseline metabolic rate; 2) HIT would speed V02P kinetics without
affecting [HHb] kinetics; 3) the HIT-induced speeding of V02P kinetics would be
greater in the US compared to LS; and 4) the steady-state O2 cost of exercise
(A V 0 2 P/AWR) would be greater in US compared to LS.

0 2 Uptake (L/min)
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Figure I. Representative multi-phase adaptation profile of pulmonary O2 uptake
( VChp) to moderate-intensity step-increases in exercise. (Adapted from Delorey et
al., 2007.)
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Figure II. Schematic representation of the double-step, constant-load moderateintensity exercise test. The lower step (LS) involves a transition from light-intensity
exercise (20 W) to a work rate representing 50% of the difference between 20 W and
the estimated lactate threshold, 0l (A50); the upper step (US) involves a transition
from A50 to 90% 0 l . Adapted from Brittain et al., 2001.
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Chapter 2:

High-Intensity Interval Training Speeds O2 Uptake Kinetics
Moderate-Intensity Exercise Transitions Initiated from
Low and Elevated Metabolic Baselines
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2.1 Introduction
During a step increase in exercise intensity from rest or light-intensity
exercise, there is an immediate increase in ATP turnover in the working muscle (35).
During transitions into the moderate-intensity (MOD) domain of exercise, i.e., below
the lactate threshold (0l ), pulmonary O2 uptake (V 0 2 P) does not increase
instantaneously, but rather, rises with an exponential time course towards a new
steady-state level, after allowing for the transport delay between the active muscle
and the pulmonary circulation (58, 59). The kinetics of the fundamental phase II
V02P response during MOD exercise reflect the adjustment of mitochondrial O2
utilization in the working muscle. Additional energy requirements not met by
oxidative phosphorylation are met through substrate-level phosphorylation with
consequent breakdown of phosphocreatine (PCr) and glycogen (9, 29, 35, 54).
When exercise transitions are initiated from an elevated baseline to work rates
(WR) within MOD (9, 10, 33, 41, 55) or the heavy- or very-heavy-intensity domains
(33, 60, 61), the time course of adjustment of V02P is slower than when starting from
a low or resting metabolic rate. Additionally, the fundamental V02P gain (G;
AV02P/AWR), a measure of the O2 cost of exercise, is greater for exercise initiated
from a higher compared to lower metabolic rate (9, 10, 41, 55, 60, 61).
Slowed VChP kinetics in the upper region of the MOD domain may reflect the
distinctive energetic (i.e., differing mitochondrial content and total [creatine]) or
vascular control characteristics of the newly recruited motor units (10, 33). MacPhee
et al. (41) reported that the rates of adjustment of heart rate (HR) (reflecting cardiac
output dynamics), femoral (conduit) artery blood flow (LBF) and leg vascular
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conductance dynamics were slowed; additionally, the ALBF/A VChP ratio was higher
in transitions performed from an elevated metabolic rate, suggesting a potential
limitation due to the adjustment of blood flow and muscle O2 delivery. However,
Bowen et al. (9) suggested that muscle oxygenation alone could not explain the
slowed VChp kinetics in the upper region of MOD, and that a less favorable energetic
state and reduction in available free energy from ATP hydrolysis (AGatp) may
provide an additional limitation to V (h P kinetics when exercise is initiated from an
elevated baseline (9, 27). The specific contributions of processes governing the
observed slowing of upper step VChp kinetics have yet to be determined.
The performance of low-volume, high-intensity interval training (HIT) has
been shown to promote rapid adaptations in skeletal muscle and exercise performance
(14, 24, 43). The comparison of HIT (in numerous work-rest ratio variations) to
endurance training (END) has consistently underlined the effectiveness of HIT in
developing gains in maximal VChp, work capacity, muscle oxidative capacity and
vascular function (13, 24, 31, 37, 52). The effectiveness of HIT has additionally been
highlighted in its ability to improve performance in elite athletes, where END has
been shown to be ineffective (38). The effects of 4 to 6 weeks HIT and sprint-interval
training (SIT; short, repeated bouts of “all-out” sprinting) have been widely
demonstrated; however, very short-term HIT and SIT alone have been found to
induce rapid physiological adaptations. Burgomaster et al. (12, 14) observed increases
in resting muscle glycogen, mitochondrial citrate synthase (CS) and pyruvate
dehydrogenase (PDH) activity, and improved time trial (TT) performance following 6
sessions (2 weeks) of SIT. Gibala et al. (26) reported immediate increases in markers
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of mitochondrial biogenesis following a single session of SIT (total of 2 min; <80kJ
total work). These reports clearly illustrate the potency of HIT and SIT, and their
ability to produce rapid changes in skeletal muscle metabolism and exercise
performance. Consequently, HIT and SIT have become very popular training
strategies, as they provide benefits comparable to those observed with END, while
they require only a fraction of the time commitment.
Numerous investigations have observed the effects of END on VChp kinetics;
however, while the effects of HIT on exercise performance and muscle metabolism
have been examined (see (25, 37) for review), fewer studies have investigated the
effects of HIT on VChp kinetics (6, 36, 43, 47). McKay et al. (43) recently compared
the effects of END and HIT on VChp kinetics within the MOD domain, and exercise
performance during severe-intensity exercise. They observed a similar speeding of
V02p kinetics and improvements in performance following both HIT and END
training, and suggested that the speeding of VThP kinetics occurred very early in the
training programme (within two training sessions). However, given the slower VThP
kinetics observed when initiating exercise transitions from a higher compared to a
low metabolic baseline, and the positive effects of HIT on muscle metabolic and
vascular function, it was of interest to examine whether VChp kinetics in the upper
region would become faster in response to a HIT programme.
Therefore, the primary goal of this study was to investigate the effects of HIT
on VChp kinetics during transitions from low and elevated metabolic rates, within the
MOD domain. The following hypotheses were tested: 1) in transitions to MOD
exercise, both V02P and [HHb] kinetics would be slower when exercise was initiated
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from a high (upper step; US) compared to a low (lower step; LS) baseline metabolic
rate; 2) HIT would speed VChp kinetics without affecting [HHb] kinetics; 3) the HITinduced speeding of VChp kinetics would be greater in the US compared to LS; and
4) the steady-state O2 cost of exercise (A VChp/AWR) would be greater in US
compared to LS.
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2.2 M ethods
Subjects

Eight young, healthy adult men were recruited to complete the high-intensity
interval training programme (HIT; 27 ± 6 y (mean ± SD), 82 ± 5 kg). An additional 5
young, healthy men were recruited to serve as control subjects (CON; 23 ± 3 y, 79 ± 9
kg) and completed all aspects of the experimental protocol except for the highintensity training. All participants were untrained, recreationally active (other lightto-moderate intensity activities up to 2-3 times per week), and were asked to continue
their regular daily activities for the duration of the study. All participants reported
being healthy, without current or history of cardiovascular, respiratory, metabolic or
musculoskeletal disease, and none were smokers or taking any medications that might
affect the cardiovascular or hemodynamic responses to exercise.

The protocol,

including possible risks and discomforts related to the testing and exercise training,
was provided to the subjects both verbally and in writing before the start of data
collection. Participants were instructed to maintain their normal diets over the course
of the study. Subjects provided written informed consent before voluntary
participation in this study.

All procedures in this study were approved by The

University of Western Ontario Ethics Committee for Research on Human Subjects.
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Experimental Protocol

Exercise Testing
At the start of the study (pre-training, PRE), all participants visited the
laboratory for an initial ramp incremental plus constant-load, step exercise (RISE105) test to volitional fatigue to determine their maximal VCEp (VChmax) and
estimated lactate threshold (0 l ). Over the following two visits, they completed steptransitions in work rate (WR) from a baseline of 20 W to a final intensity representing
90%

0l

(i.e., within the moderate-intensity exercise domain; MOD) performed either

as a i) single-step protocol (single step (SS), 20 W—>90%), or ii) as a double-step
protocol where the increases in WR were performed as two identical step-transition
increments in WR from 20 W to ~ 45%
transition from ~ 45%

0l

to 90%

0l

0l

(lower step, LS), followed by a step-

(upper step, US). Each step-transition lasted 6

min and each step protocol was repeated either 3 (single-step) or 5 times (double
step). Also, the effectiveness of the HIT programme was assessed by means of a timeto-fatigue (TTF) performance test consisting of a constant-load cycling test performed
at the maximal WR (WRmax) achieved during the pre-training RI exercise test. For
the HIT group, the RISE-105 exercise test, MOD step-transitions and TTF test were
repeated following 6 training sessions (after ~2 weeks; MID) and 12 training sessions
(after ~4 weeks; POST). The CON group performed identical sets of testing separated
by 2- (MID) and 4-weeks (POST). For both the HIT and CON groups, a final
“verification” (VER) testing session was performed 4-5 days following POST testing
and consisted of a RISE-105 test, single-step MOD transitions (total of 3 transitions),
double-step MOD transitions (total of 5 transitions) and a TTF test. The timelines of
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testing and training for both groups are illustrated in Figure 1. Testing at the PRE,
MID, POST, and VER times was intended to establish a time course for physiological
adaptations and performance enhancements over the course of the 12 HIT sessions.
The MOD exercise transitions were performed at VER in order to confirm that any
changes in V02P kinetics were a result of longer-term HIT training, and not a
consequence of short-term effects resulting from the previous (final) exercise training
sessions. Participants abstained from caffeine for at least 3 h, and from alcohol for at
least 12 h prior to all testing.
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Figure 1. Testing and training timelines for A) HIT training group and B) control
(CON) group. ** completion of one RISE-105 test, one TTF test, 3 single-step
moderate intensity exercise tests (SS-MODs) and 5 double-step moderate intensity
exercise tests (DS-MODs). *completion of one RISE-105 test, one TTF test and 5
DS-MODs. Boxes indicate training session, numbers indicate number of highintensity interval repetitions completed during training session.
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Ramp Incremental Exercise (RISE-105) Test
Participants completed a ramp incremental (RI) exercise test (20 W/min) to
their limit of tolerance at each of the PRE, MID, POST and VER time points. The RI
test was performed on an electromagnetically-braked leg cycle ergometer (H-300-R
Lode; Lode B.V., Groningen, Holland), and was used to determine both maximal O2
uptake (VGhmax) and estimated lactate threshold

( 0 l ).

The

0l

was determined

visually as the V02P at which the rise in CO2 output (VC02P) became
disproportionate to the rise in V 0 2 P, with a systematic increase in the ventilation-toV 0 2 P ratio (V e/V 0 2 P) and end-tidal P 0 2 , and where the ventilation-to-VC 0 2 P ratio
(V e/V C 0 2 P) and end-tidal PCO 2 remained stable (5). A value for

0l

was identified

for each of the listed criterion, and those values were averaged together to attain a
final estimate for

0l

. The V02max attained at the end of the RI test was verified using

a RISE-105 protocol (53): following the point of volitional fatigue at the end of the
RI test, the WRmax was noted, and the WR was returned to 20 W. Participants
continued cycling at 20 W for 5 min, after which the WR was increased as a stepfunction to 105% WRmax (SE-105). The Lode ergometer required 10 - 20 s to attain
the 105% WRmax. Participants cycled at this higher WR until they could no longer
maintain a cadence above 50 revolutions per minute (rpm) despite strong, verbal
encouragement.

Moderate Intensity Step-Transition Tests
Five repetitions of the double-step MOD transition tests (DS-MOD) were
completed on a cycle ergometer (H-300-R Lode; Lode B.V., Groningen, Holland) at
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each of the PRE, MID, POST and VER testing points. Additionally, 3 repetitions of
the single-step MOD transition tests (SS-MOD) were completed at both the PRE and
VER points. In the SS-MOD, 6 min of cycling at a baseline of 20W was followed by
A

an instantaneous step-transition to a WR corresponding to 90%

0l

for an additional

6

min. For the DS-MODs, participants cycled for 6 min at 20W, followed by two 6 min
step transitions; the first lower step (LS) involved an instantaneous increase to a WR
A

to midway between 20W and the WR corresponding to 90%

0l

(A50), and the

second upper step (US) involved an instantaneous increase in WR from A50 to a WR
A

•

corresponding to 90% 0l . Transitions lasted 6 min to allow the achievement of VChp
steady-state. Participants maintained a cadence of 70 rpm during these tests. Because
HIT was performed on alternate days, it was not possible to perform only single
transitions per day, therefore multiple transitions were performed on the same day,
each MOD test was separated by 10 min.

It has been previously shown that

parameter estimates (time constant, time delay, amplitude) for V 0 2 P and
deoxygenation ([HHb]) kinetics do not differ when transitions are completed either
on separate occasions, or sequentially as a series of transitions (2 or 6), each separated
by 6 min baseline cycling (56).

Time-to-Fatigue Performance Test
Participants completed a constant-load time-to-fatigue performance test on a
cycle ergometer (H-300-R Lode; Lode B.V., Groningen, Holland) at each of the PRE,
MID, POST and VER testing points. The test involved an initial 5 min warm-up,
cycling at 20 W, followed by an instantaneous increase in WR to 100% of the WRmax
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attained during the PRE RI test. Participants were instructed to maintain a cadence of
at least 70 rpm; the test was stopped when subjects could not maintain a cadence of at
least 60 rpm, despite strong verbal encouragement.

High-Intensity Training (HIT) Protocol
All training was completed on a friction-braked cycle ergometer (Monark
Ergomedic 874E, Monark, Vansbro, Sweden), with the investigator always present.
Each HIT session began with a 5 min warm-up with no external resistance applied
(“loadless”). Following the warm-up, training participants cycled for 1 min at 110%
of the WRmax attained during the RI test. Work intervals were followed by 1 min of
“loadless” cycling. Intervals were repeated 8 times during the first training session,
progressing to a total of 12 intervals by the final (twelfth) training session.
Participants cycled at a self-selected cadence between 80-100 rpm, and maintained
that cadence across all work intervals of the training sessions. Total work and
adherence to the selected cadence were recorded for each HIT session. After every
two training sessions, the cycling load was increased by ~2-4% in order to promote
continuous improvements in training performance. During the sessions, participants
were provided with strong verbal encouragement, were allowed water ad libitum, and
remained on the cycle for the entire duration of the session.

Training and Testing Timelines
PRE testing was completed during three visits, totaling ~ 2.5 hrs. After 1-2
days, the HIT group began training with 1-2 days rest between sessions. Each training
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session required 20-30 min for completion. After completion of 6 HIT sessions (~2
weeks), the HIT group completed MID testing during two visits, totaling ~ 2 hrs. The
HIT group completed another 6 training sessions (~2 weeks), followed by POST
testing. Post-training tests were completed during 2 visits, totaling ~ 2 hrs. VER
testing was performed 4-5 days after the POST testing, and required ~ 2.5 hrs during
2 visits. On average, participation in this study required 5-6 weeks for completion.
CON participants completed all testing along a timeline identical to the HIT
group, but did not complete any HIT training sessions. The CON group was asked to
maintain their regular recreational activity (2-3 times per week), without additional
training.

Data Collection

Gas exchange measurements were similar to those previously described by
(1). Briefly, inspired and expired flow rates were measured with a low dead space (90
ml) bidirectional turbine (Alpha Technologies VMM 110), which was calibrated prior
to each test with a 3.0 L syringe. The inspired and expired gases were sampled
continuously (every 20 ms) at the mouth and analyzed for concentrations of O2, CO2,
and N 2 by mass spectrometry (Innovision, AMIS 2000, Lindvedvej, Denmark)
following calibration with precision-analyzed gas mixtures. Changes in gas
concentrations were aligned with gas volumes by measuring the time delay for a
square-wave bolus of gas passing through the turbine to the resulting changes in
fractional gas concentrations (measured by the mass spectrometer). Data were
transferred to a computer, which aligned the concentration and volume information to
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build a profile of each breath. Breath-by-breath alveolar gas exchange was calculated
using algorithms of (4). Heart rate (HR) was continuously monitored by three-lead
electrocardiogram using PowerLab (ML132/ML880; ADInstruments, Colorado
Springs, CO, USA) on a separate computer.
Local muscle deoxygenation and oxygenation profiles of the quadriceps
vastus lateralis muscle were measured using near-infrared spectroscopy (N1RS) (ISS
OxiplexTS, ISS Inc., Champaign, Illinois). The rigid sensor was placed on the belly
of the muscle, midway between the lateral epicondyle and greater trochanter of the
femur. Emitter fibers and detector were housed in a rigid, plastic sensor casing,
ensuring that their positions remained fixed. The sensor was clipped on to a velcro
strap, which was wrapped around the participant’s leg to secure its position.
Additionally, an optically-dense black vinyl sheet was placed overtop and around the
sensor casing (minimizing the intrusion of extraneous light and loss of NIR light).
The thigh, with attached sensor and covering, was wrapped with an elastic bandage to
minimize any movement of the sensor.
The theory of tissue spectroscopy has been previously described by Elwell
(22).

Briefly,

the

Oxiplex

TS—providing

multidistance

frequency-domain

spectroscopy (fd-NIRS)—had 4 pairs of laser diode light sources at two different
wavelengths (690 nm and 828 nm). Light from the diodes was coupled to fibers that
carried the light to the tissue under investigation. The light was received by another
detector fiber, then carried back and detected by a photomultiplier tube in the
spectrometer. The diodes were set at source-detector distances of 2, 2.5, 3 and 3.5 cm.
After the rigid sensor was secured on the leg, detector gain was adjusted for an
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optimal signal as the subject rested on the cycle ergometer (detector “gain” is
dependent on detector bias voltage, where a larger voltage produces a larger signal).
The OxiplexTS produced 25 measurements per second; averaged measurements were
displayed and recorded at a frequency of 1 Hz. Recorded data provided measured of
concentration changes in oxyhaemoglobin (C^Hb), deoxyhaemoglobin (HHb), and
total haemoglobin (Hbyoi), as well as changes in the percentage of O2 saturation
(%SAT). The ability of fd-NIRS to adjust for scattering coefficient, along with a
variable (unfixed) path-length, allowed for the measurement of absolute concentration
changes in OiHb and HHb.

Data Analysis
Breath-by-breath VChp data were filtered by removing aberrant data points
that lay outside 4 SD of the local mean. The remaining data were interpolated to 1 s
intervals, and time-aligned such that time “zero” represented the onset of the MOD
exercise transition (in case of the DS-MODs, the first step transition). The data from
test repeats were ensemble-averaged, and further time-averaged into 5 s bins to yield
a single profile for each subject at each testing period. The phase I-phase II transition
was identified as previously described (30, 54). On-transient phase II V02P kinetics
were modeled using the following equation:
Y (t) = Y

Where

Y ( t)

bsln

+ Amp (1 - e'0™ )

represents

V 0 2 P

at any time (t);

(Eq. 1)
Y

bsln

is the baseline value of

V 0 2 P

immediately before the change in WR; Amp (amplitude) is the steady-state increase
in V 0 2 P above the baseline V 0 2 P; x (time constant) represents the time required to
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attain 63% of the steady-state amplitude; and TD is the time delay (mathematically
generated as the point at which the exponential model is predicted to intersect the
baseline). Data were modeled from the phase I-phase II transition to the end of the 6
min exercise transition using Origin data fitting software (OriginLab). The 95%
confidence interval (CI95) for the estimated time constant was determined following a
preliminary fit with

Y

b sln

,

Amp and TD constrained to best-fit values, with the

x

allowed to vary. The mean response time (MRT) (40) of V02P described the overall
time course of VC>2P during the exercise transition and was estimated using the
function described in Eq. 1, but with inclusion of all VChP data from the onset of
exercise, and the TD constrained to 0 s. This approach allowed for an estimate of the
O2 deficit (54) for each WR transition. The O2 deficit provides information on nonoxidative energy transfer, and was calculated as:
O2 deficit (L) = MRT (s) x A VCEss (L/min) x min/60 s
(Eq. 2)
The functional gain of the fundamental VO2 response was calculated as AVChss /
AWR (mL/min/W).

NIRS-derived data were time-aligned and ensemble-averaged into 5 s bins to
yield a single response time for each subject. The time-course of adjustment for
[HHb] has been described to consisted of a TD following the onset of exercise, with a
subsequent “exponential-like” increase in the signal of time (17). The TD for the
[HHb] ([HHb]ro) response was determined using second-by-second data, and was
identified as time, following exercise onset, at which the [HHb] signal began to rise
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systematically. [HHb]xD was determined for individual trials, and averaged for each
LS, US and SS, at each testing point, for each subject. The ensemble-averaged [HHb]
responses were modeled from [HHb]xD to 90 s of the transition, with a
monoexponential function of the form in Eq. 1 to determine the time course of muscle
[HHb] (x[HHb]). Baseline [HHb] ([HHb]BSLN) was determined for each of the US and
LS as the mean value in the 60 s prior to a transition. The effective time constant (x’ =
[HHb]xD + x[HHb]) was calculated to describe the overall time course for muscle
[HHb]. The gain of muscle deoxygenation was calculated as A[HHb] / A VChp.
Second-by-second VChp and [HHb] data were normalized for each subject (0100% of response). VChp data were left-shifted by 20 s to account for the phase Iphase II transition, in order to align the onset of transition with the start of the VChp
phase II response. Data were further averaged into 5 s bins in order to statistically
compare the time courses of adjustment for VChp and [HHb]. A mean A[HHb]-toA VChp ratio was determined across 20-180 s of each transition, at each testing point
for each subject. This time window was selected to fall beyond the NIRS-derived
[HHb]xD, and simultaneously allow for both VChp and [HHb] signals to reach 100%
of their amplitudes.

Statistical Analysis

Data are presented as means ± SD. Repeated measures analysis of variance
(ANOVA) was used to determine statistical significance for the dependent variables;
repeated factor of time (PRE, MID, POST and VER), and between factor of group
(HIT, CON). Where group x time interactions were identified, a one-way ANOVA

36
was further performed to identify changes over time within groups. Tukey post-hoc
analysis was used when significant differences were found for main effects. ANOVA
was analyzed using SPSS Version 17.0 (SPSS Inc., Chicago, IL). Statistical
significance was accepted at P < 0.05.
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2.3 Results
Exercise Performance (TTF and Training)

While relative intensity remained constant across the 12 training sessions,
training interval power output and exercise volume were increased (P < 0.05) during
the final 6 training sessions (see Table 1).
Exercise performance in the TTF and RISE-105 tests improved in the HIT
group over the course of the 12 training sessions, while CON group showed no
changes (Table 2). The time-to-fatigue (TTF) when exercising at the constant WRmax
achieved in the initial (PRE) RI test increased by 85% (P <0.01) from PRE to VER,
while the WRmax achieved during RI testing increased by 17% (P <0.01) during this
same period. Improvements for both TTF and RI WRmax were observed from PRE to
MID (P < 0.05), and MID to POST (P < 0.05); no differences occurred between
POST and VER. There were no differences present at baseline (PRE) TTF or WRmax
between the HIT and CON groups.

Maximal O2 uptake and Lactate Threshold

In general, no differences existed between the three measures of V02P
indicating that V02max was established at each time point (PRE, MID, POST and
VER) (see Figure 2).
In the HIT group, absolute V02max increased by 17% (P <0.01) and relative
V02max increased by 16% (P < 0.05) from PRE to VER (Table 2). The VChmax in the
CON group did not change at any testing time. While VChmax (absolute and relative)
at baseline (PRE) tended to be higher in the CON group compared to the HIT group
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(3.95 ± 0.37 L/min and 3.41 ± 0.54 L/min, respectively; P = 0.08), statistically
significant differences were not found between groups at this time point.
In the HIT group, the WR and V02P corresponding to the estimated lactate
threshold

(0 l

) increased from PRE to MID (P < 0.05), and MID to POST (P < 0.05),

with no changes POST to VER (see Table 2); the increases from PRE to POST
training were 20% (P <0.01) and 35% (P < 0.01), respectively, relative to V02P and
WR (Table 2). The

0l

remained unchanged in CON throughout the study. The

A

0l

was not different between groups at the start of training.
During PRE, the end-step, steady-state V02P for the LS and US represented

72% and 98% of PRE

0l

, and 42% and 58% of the PRE VO^max. Slow-component

responses were not observed in the individual V 0 2 P transition data, indicating that
subjects exercised within the MOD domain during constant-load, step-transition tests.
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Table 1. Training protocol, average work and time per training session
HIT sessions 1 to 6
-1 1 0 % VOamax
Relative Intensity
(-3 1 5 W)
- 168 kJ
Total exercise volume
9 min
Total exercise time
23 min
Total time with rest and warm-up
HIT, high-intensity interval training; V02max, maximal O2
volume and relative intensity per session results are based
sustained during work intervals, and do not include loadless
different (P <0.01) from sessions 1 to 6.

HIT sessions 7 to 12
~ 110% VC>2max
(~ 335 W *)
- 222 kJ *
11 min
27 min
uptake. Total exercise
on average workloads
cycling. ^Significantly
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Table 2. Training responses for aerobic and performance parameters assessed during
ramp incremental and time-to-fatigue testing
Mid

Post

Ver

3.61 ±0.64*
46 ±6 *
316 ± 49 *
2.15 ±0.34 *
133 ±23 *
283 ±38 *

3.88 ± 0.69*t
49 ± 5*t
336 ± 51*t
2.38 ± 0.46*f

4.00 ± 0.66*f
50 ± 5*f
340±48*t
2.35 ± 0.45*t
158 ± 25*f
386 ± 63*f

Pre

Parameter

HIT
VChmax , L/min
VChmax, mL^kg'^min'1
WRmax, w
Estimated 0 l , L/min
Estimated 0 l , W
Time-to-fatigue, s

3.41 ±0.54
43 ±4
291 ±45
1.99 ±0.26
117 ± 21
209 ±51

158 ± 30*t
370 ± 78*f

CON
3.89 ±0.41
3.98 ±0.38
3.95 ±0.37
3.89 ±0.35
49 ±4
48 ±4
47 ±4
48 ±5
318 ± 42
321 ±44
320 ± 48
319 ± 38
2.15 ±0.11
2.15 ±0.21
2.16 ± 0.11
2.16 ± 0.16
Estimated 0 l , L/min
128 ± 15
129 ±23
116 ± 18
122 ± 17
Estimated 0 l , W
195 ±32
198 ±38
Time-to-fatigue, s
207 ± 58
206 ± 29
Values are means ± SD; VChmax, maximal O2 uptake; WRmax, work rate at maximal
O2 uptake; 0 l , lactate threshold. Pre, pre-training; Mid, mid-training; Post, post
training; Ver, verification. *Significant (P < 0.05) difference from Pre. f Significant
(P < 0.05) difference from Pre and Mid.
VChmax, L/min
VChmax, mL^kg'^min'1
WRmax, W

A
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Figure 2. Mean maximal V02P for HIT group at at different testing points, for timeto-fatigue (TTF), ramp incremental (RI) and step-exercise transitions to 105% peak
work rate (SE-105). PRE, pre-training; MID, mid-training; POST, post-training;
VER, verification. Black bars indicate TTF-derived values, light grey bars indicate
Rl-derived values, and dark grey bars indicate SE-105% derived values. *Significant
difference from PRE (P < 0.05). **Significant difference from PRE and MID (P <
0.05). #Significant difference from TTF (P < 0.05).
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VChp kinetics
Table 3 outlines VChp kinetic parameters for both HIT and CON groups, at
PRE, MID, POST and VER testing points. Figure 3 shows the group mean, ensembleaveraged VChp response profiles for the double (3A, 3B) and single (3C, 3D) steptransitions within the moderate-intensity domain for the HIT group at PRE and VER.
The V02P response profiles for a representative HIT subject are shown in Figure 4.
Prior to the start of training there were no differences between the CON and HIT
groups for any of the V 0 2 P parameter estimates (xV 0 2 P, V 0 2 PSS, VChpbsi, V 0 2 P
amplitude, TD), the VChp gain (A VChpss /AWR) or O2 deficit. Changes in LS or US
V 0 2 p kinetic parameters were not seen in CON across testing periods.
Lower Step. In the HIT group, xVChp was reduced by 38% from PRE to
POST (24 ± 6 s and 15 ±

2

s, respectively; P < 0.01). No differences in xV02P

occurred between POST (15 ± 2 s) and VER (14 ± 3 s). TD in the HIT group
increased from PRE to POST (13 ± 4 s and 20 ± 2 s, respectively; P < 0.05), with no
differences occurring between POST and VER. No changes in VChpss, VChpbsi,
V 0 2p amplitude, VChp gain or O2 deficit occurred as a consequence of the training
programme. No significant changes occurred over time in CON subjects.
Upper Step. In the HIT group, x VChp was significantly reduced by 38% from
PRE to POST (45 ± 5 s and 28 ± 7 s, respectively; P < 0.01). No change in x VChp
occurred between POST and VER. The HIT group TD increased from PRE to POST
(5 ± 10 s and 11 ± 6 s, respectively; P < 0.05), with no differences occurring between
POST and VER. O2 deficit was reduced by 22% from PRE to POST (423 ± 125 mL
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and 329 ± 76 mL, respectively; P < 0.05), with no differences between POST and
VER. No changes in V02Pss, V02PbSi, V02P amplitude orV02P gain occurred as a
consequence of the training programme. There were no changes in the CON group
over time.
Upper Step vs. Lower Step. The US x V02P was consistently greater than that
of the LS, not only at baseline (PRE) and in the CON group, but even remained
greater across the 12 training sessions in the HIT group (P < 0.05 for all time points,
in both HIT and CON). The V02P gain at PRE was greater in the US and LS, both in
HIT and CON groups (P < 0.01 for both). No changes in US or LS V02P gain
occurred over time in either group. While the O2 deficit in the HIT group US was
nearly double that of the LS at PRE (423 ± 125 mL and 265 ± 58 mL, respectively; P
< 0.01), these differences were abolished at VER (LS, 246 ± 73 mL; US, 303 ± 100
mL; P = 0.10).
Single Step. HIT group x V02P was reduced from PRE to VER by 41% (32 ±
7 s and 19 ± 3 s, respectively; P < 0.01). The O2 deficit decreased in the HIT group by
20% (661 ± 110 mL and 527 ± 102 mL, respectively; P < 0.01). There were no
changes in V02PSS, VChPbsi, VC>2P amplitude, or V02P gain (A VC>2Pss/AWR). CON
group xV 0 2 P, V 0 2p gain and O2 deficit remained unchanged over time; however,
both V02Pbsi and V02PSS were both reduced at (P < 0.05) VER.

Table 3A. VChp kinetic parameters for lower step (LS) and upper step (US) moderate-intensity exercise transitions, at pre-training, mid-training,
post-training and verification testing points
Parameter

Pre
LS

Mid
US

LS

Post
US

Ver

LS

US

LS

US

HIT
VChp bsi L/min
VChp ss, L/min
Amp, L/min
TD, s
TVChP, s
C95, L/min
AVChpSs/AWR,
mL^min^W’1
O2 deficit, mL

VChpbi, L/min
V 0 2pss, L/min
Amp, L/min
TD, s
t V ChP, s

C95, L/min

AVChpSs/AWR,
mL^min^W’1
O2 deficit, mL

0.98 ± 0.09

1.46 ± 0.15

0.98 ±0.10

1.47 ±0.17

0.94 ± 0.06

1.43 ±0.13

1.44 ±0.14
0.44 ±0.12
13 ± 4
24 ±6
5± 1

1.50 ±0.29
1.96 ±0.24
0.52 ±0.11
5 ± 10
45 ±5
5 ±2

1.45 ±0.15
0.47 ±0.13
16 ± 5 *
18 ± 3 *
4± 2

1.97 ± 0.27
0.52 ±0.13
6±6
35 ± 8 *
5±2

1.47 ± 0.17
0.49 ±0.12
20 ±2 *
15 ± 2 *
4± 1

2.00 ± 0.26
0.54 ±0.11
11 ±6 f
28 ±7 f
4± 1

1.43± 0.13
0.49 ±0.12
20 ±6 *
14 ±3 f
3± 1

1.94 ±0.23
0.51 ±0.11
13 ± 9 t
25 ± 8 t
4±2

8.4 ± 1.2

10.0 ± 1.0

8.9 ± 1.3

9.9 ± 1.3

9.3 ± 1.1

10.3 ±0.4

9.5 ±0.1

9.7 ±0.8

265 ± 58

423± 125

249 ± 89

347 ±117
CON

270 ± 78

329 ± 76 *

246 ± 73

303 ± 100 t

1.05 ±0.09
1.49 ± 0.12
0.44 ± 0.08
17 ± 5
22 ± 13
5± 5

1.49 ± 0.12

1.46 ± 0.12

1.00 ±0.14

1.43 ±0.12

0.94 ± 0.08

2.00 ±0.19
0.51 ±0.08
10 ± 6
38 ±14
5±2

1.03 ± 0.11
1.46 ±0.12
0.42 ± 0.08
10 ± 14
24 ±9
6± 3

1.95 ± 0.17
0.49 ± 0.08
8± 3
38 ± 13
6± 1

1.43 ±0.12
0.44 ± 0.09
16 ± 8
23 ± 10
5± 1

1.64 ±0.63
0.48 ± 0.07
10 ± 5
36 ±7
5± 1

1.38 ± 0.10
0.44 ±0.11
13 ± 6
22 ±9
6± 3

1.38 ± 0.10
1.89 ± 0.17
0.51 ±0.08
4±7
40 ± 10
6± 2

8.9 ± 1.0

10.3 ±0.7

8.6 ± 1.3

10.1 ± 1.5

8.9 ± 1.3

9.9 ± 1.7

9.0 ± 1.6

10.3 ±0.8

298 ± 65

382 ±53

221 ±72

398 ±77

285 ± 49

335 ±97

259 ± 66

371 ±59

1.00 ±0.09

Values are means ± SD; VChpbsi, baseline VChp; V02Pss, steady-state VChp; Amp, amplitude of VChp response; TD, time delay; x VChp, time
constant for VChp response; C95, 95% confidence interval of x VChp; AV02Pss/AWR, functional gain. ^Significant (P < 0.05) difference from
Pre. fSignificant (P < 0.05) difference from Pre and Mid.
Table 3B. VChp kinetic parameters for single step (SS) moderate-intensity exercise transitions, at pre-training and verification testing points
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Parameter

Pre

Ver

SS

s s

HIT
V 0 2pbsi L/min

1.05 ±0.13

1.00 ±0.08

V 0 2pss, L/min

2.00 ± 0.20
0.94 ±0.19
9±6
32 ±7
4±1

1.97 ±0.24
0.97 ± 0.24
16 ± 3*
19 ± 3*
3± 1

9.1 ± 0.9

9.3 ± 1.0

661 ±110
CON

527 ± 102*

1.11 ±0.11
2.01 ±0.12
0.99 ±0.17
9±6
34 ± 11
3± 1

0.98± 0.10*
1.88 ±0.07*
0.90 ±0.11
7 ± 13
32 ± 13
4±2

Amp, L/min
TD, s
xVChp, s

C95, L/min
A V 0 2 Pss/AWR,

mL^min^W'1
O2 deficit, mL
V 0 2pbi, L/min

V 0 2pss, L/min
Amp, L/min
TD, s
xVChp, s
C95, L/min
A V 02Pss/AWR,
10.0 ± 1.9
9.3 ± 1.6
mL^min^W'1
O2 deficit, mL
638 ± 108
617 ±79
Values are means ± SD; V 02Pbsi, baseline VChP; V 0 2 Pss, steady-state VChP; Amp, amplitude of V 02P response; TD, time delay; x V 02P, time
constant for V 02P response; C95, 95% confidence interval of x V 0 2 P; A VChPSS/AWR, functional gain. *Significant (P < 0.05) difference from
Pre. tSignificant (P < 0.05) difference from Pre and Mid.
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Figure 3. Ensemble-averaged breath-by-breath VChP responses of HIT group to
moderate-intensity step tests; 3A) absolute VChP response to LS and US transitions in
double-step, constant load tests, and 3B) relative VChP response to LS and US
transitions in double-step, constant load tests (data normalized to the end-exercise
VChP); 3C) absolute VChp response to SS transitions, and 3D) relative VChp
response to SS transitions (data normalized to the end-exercise VChp); open circles
(O ) represent pre-training tests, closed circles ( • ) represent post-training tests at
verification.
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Figure 4. Breath-by-breath VChp responses to moderate-intensity step tests of a single
representative subject in HIT group; 4A) pre-training V 0 2 Presponse to LS and US
transitions in double-step, constant load tests, and 4B) post-training (at verification
testing) VChp response to LS and US transitions in double-step, constant load tests;
4C) pre-training V02P response to SS transition, and 4D) post-training (at verification
testing) V02P response to SS transition.
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NIRS-derived [HHb] kinetics and muscle oxygenation parameters
Table 4 shows [HHb] kinetic parameters for HIT and CON groups, at PRE,
MID, POST and VER time points. The effective time constant (x’) was consistently
larger in the US compared to the LS, in both the HIT and CON groups (P < 0.05 at all
time points). Despite a significant lowering of xV02P following 12 sessions of HIT,
there was no change in the adjustment of [HHb] (x[HHb] and x’) in the SS, LS or US
transitions. The CON group also did not experience any changes over time in x[HHb]
and x’. In both the HIT and CON groups there were no changes in [HHb] kinetic
parameters ([HHb]bsi, [HHb]ss, [HHb] end-step, and AHHbss/A V02Pss) for LS, US or
SS at any of the training-related testing times.
Figure 5 shows ensemble-averaged absolute and normalized [HHb] responses
to MOD step-transitions (LS, US and SS) in the HIT group, at PRE and VER. These
responses in a representative HIT subject are shown in Figure 6. As evidenced in Fig.
5B the [HHb] profile exhibited a transient overshoot during the LS prior to testing
that was not seen during VER. This overshoot was observed in 6 of 8 HIT subjects
and was not evident at MID, POST or VER; in CON the overshoot was observed in 3
of 5 subjects at both PRE and VER.
Table 5 shows the baseline and end-transition values for total oxygen
saturation (%SAT), oxyhaemoglobin (02Hb) and total haemoglobin (Hb-ro-r) for HIT
and CON groups, at PRE, MID, POST and VER. No changes occurred in OiHb or
HbxoT for either group; however, %SAT decreased following 12 sessions of HIT in
the training group (P < 0.05). In the DS-MOD tests for the HIT group, end-LS values
were significantly lowered at VER compared to PRE, while the values at both
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baseline and end-US tended to be lowered as well (P = 0.09 and 0.07, respectively).
Comparisons between MID and VER, however, showed significant reductions of
%SAT at all levels (i.e. baseline, end-LS and end-US). In the HIT group SS-MOD
tests, %SAT clearly decreased for the end-step (P < 0.05) between PRE and VER
testing points; significance was not found for a change in baseline %SAT. No
changes

in

%SAT

occurred

for

the

CON

group

over

time.

Table 4A. [HHb] kinetic parameters for lower step (LS) and upper step (US) moderate-intensity exercise transitions, at pre-training,
mid-training, post-training and verification testing points
Parameter

Mid

Pre
LS

US

LS

Post
us

Ver

LS

us

LS

US

H IT

[HHb]hsi, AU
[HHb]ss, AU
[HHbJ
End-Stp, AU
TD, s
x[HHb], s
T\ s

A[HHb]ss
/A V 0 2 p ss

28.1 ±5.1
34.5 ±7.8

34.4 ±8.1
40.1 ±9.5

27.3 ±4.6
31.9 ±6.4

32.1 ±6.7
38.0 ±8.2

30.7 ±5.2
37.1 ±6.9

37.3 ±6.8
43.8 ±9.3

31.9 ± 3.5
37.7 ±6.6

39.2 ±7.0
46.4±11.2

34.2 ±7.5

41,6± 10.3

32.2 ± 6.9

38.8 ±8.6

37.3 ±6.8

44.2 ±9.2

38.0 ±5.3

46.8 ±8.9

11 ±3
8± 4
18 ± 5

9± 2
23 ± 12
32 ± 11

12 ± 2
8± 5
20 ±4

10 ± 2
23 ±8
33 ±6

12 ± 3
9± 8
21 ±6

8± 2
20 ± 14
28 ± 12

13 ± 2
8± 6
21 ±5

9± 3
20 ± 13
28 ± 13

14 ±9

14 ±8

11 ±6

14 ± 9

14 ± 8

14 ± 6

12 ± 5

15 ± 6

31.9 ± 4.3
38.0 ±7.4

27.7 ±6.6
31.5 ±6.9

31.0 ±6.8
36.3 ± 10.9

26.7 ± 7.2
30.9 ±8.4

31.3 ±7.7
36.1±10.5

38.5 ±7.5

31.0 ± 6.8

36.8 ± 11.0

30.7 ±6.6

36.7 ±9.6

13 ± 1
9±3
22 ±3

9± 1
23 ±3
31 ±3

12 ±7

13 ± 7

CON

[HHb]bsi, AU
[HHb]^,, AU

[HHb]
End-Stp, AU
TD, s
t[HHb], s
x', s
A[HHb]ss
/A V02p m

32.5 ± 7.3

32.4 ±5.6
38.2 ±8.0

32.4 ±5.6

39.4 ±7.9

11 ±3
9± 3
20 ±2

7±2
25 ± 10
32 ±9

11 ±2
7±2
18 ± 2

7±3
19 ± 7
26 ±7

11 ±4
7±4

18 ± 2

7± 1
19 ± 6
26 ±5

13 ± 3

15 ± 7

12 ±6

15 ± 9

9±4

13 ± 10

212 ± 6 2

27.1 ±3.1
32.1 ±3.6
31.9 ± 4.4

Values are means ± SD; [HHb]bSi, baseline; [HHb]ss, steady-state; [HHb] End-Stp, end-transition [HHb]; TD, time delay; x[HHb], time
constant for [HHb] response; x', effective time constant (x[HHb] + TD); A[HHb]ss, /A V02PSS, gain. No significant changes occurred
over time (P > 0.05)
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Table 4B. [HHb] kinetic parameters for single step (SS) moderate-intensity exercise transitions, at pre-training and verification testing
points
Parameter

Pre
SS

Ver
SS

HIT
[HHb]bsi, AU
[HHb]ss, AU
[HHb]
End-Stp, AU
TD, s
t[HHb], s
t

’,

s

A[HHb]Ss
/A V O2SS

27.0 ±5.2
39.6 ± 10.3

30.5 ±2.4
44.6 ±7.1

40.4 ±9.7

4 5 .5

± 7.3

10 ± 2
10 ± 4
19 ± 5

10 ± 2
11 ±6
21 ±7

15 ± 9

17 ± 10

CON
[HHb]bsl, AU
[HHb]ss, AU
[HHb]
End-Stp, AU
TD, s
x[HHb], s
t

’,

s

A[HHb]ss
/A VO 2.SS

26.7 ±3.8
38.9 ±8.4
39.9 ±9.2

27.0 ±8.3
36.6 ± 12.1
3 5 .3

± 8.5

8± 3
12 ± 3
20 ±2

8±2
12 ± 3
20 ±2

13 ±4

14 ± 10

Values are means ± SD; [HHbJbsi, baseline; [HHb]ss, steady-state; [HHb] End-Stp, end-transition [HHb]; TD, time delay; t[HHb], time
constant for [HHb] response; x', effective time constant (x[HHb] + TD); A[HHb]ss, /A V02PSS, gain. No significant changes occurred
over time (P > 0.05).
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Table 5A. Total oxygen saturation (%SAT), oxyhaemoglobin (C^Hb) and total haemoglobin (HbioT) during double-step, constant
load moderate-intensity exercise tests, at pre-training, mid-training, post-training and verification testing points
Parameter
BSL

Pre
end-LS

end-US

BSL

Mid
end-LS

end-US

BSL

Post
end-LS

end-US

BSL

Ver
end-LS

end-US

70.9
±2.9
74.7
±7.0
105.1
± 10.7

66.4
±4.6
73.5
±7.8
110.7
±11.3

61.5
±6.2
69.7
±9.4
113.7
± 12.9

68.9
± 2.9'f
71.4
±8.2
103.2
±9.9

65.4
±3.2 *t
71.7
±7.6
109.6
± 10.7

59.0
± 6.7 f
67.5
± 10.2
114.2
± 11.7

71.0
±3.0
66.1
±8.1
93.7
± 13.9

69.0
±2.8
68.5
±7.1
99.4
± 13.4

64.6
±5.2
66.0
±3.9
102.9
± 14.1

72.1
±2.7
66.9
±8.0
92.8
± 12.8

69.1
±3.7
67.8
±5.6
99.4
± 12.4

64.6
±5.1
65.8
±3.9
102.8
± 12.4

HIT
%SAT
0 2Hb, AU
Hbroi, AU

72.1
±4.6
79.1
±23.2
107.1
±24.5

68.9
±4.9
80.7
±23.8
115.0
±27.2

63.6
±6.2
77.0
±23.1
118.6
±27.9

71.5
± 1.7
68.5
±7.2
95.8
± 11.3

68.6
±2.8
69.9
±7.1
102.1
± 13.5

64.1
±3.9
68.5
±7.9
107.3
± 15.0
CON

%SAT
0 2Hb, AU
H t> T O T >

AU

71.2
±4.1
66.1
±7.7
93.3
±11.9

67.3
±2.3
66.8
±6.9
99.3
±11.8

61.8
±3.7
63.3
±4.2
102.7
± 11.5

71.7
± 1.5
68.9
±9.6
96.0
± 12.4

68.6
± 1.3
69.5
±9.2
101.4
± 13.2

63.6
±2.8
66.1
±5.3
104.6
± 12.7

Values are means ± SD. *Significant (P < 0.05) difference from Pre. fSignificant (P < 0.05) difference from Mid.
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Table 5B. Total oxygen saturation (%SAT), oxyhaemoglobin (C^Hb) and total haemoglobin (Hbioi) during single-step, constant-load
moderate-intensity exercise tests, at pre-training and verification testing points
Parameter
Pre
Ver
__________________ BSL______ end-step______ BSL______ end-step
HIT
%SAT
0 2Hb, AU
HbxoT, AU

74.0 ±4.0
82.1 ±21.1
109.1
±22.8

64.7 ± 4.3
76.7 ± 18.4
117.0
±25.6

72.1 ± 1.7
78.9 ±8.3
109.4
±9.9

60.9 ± 5.6*
71.2 ±8.2
116.7
± 8.5

72.9 ±4.3

65.0 ±5.3
66.6 ± 11.8
102.3
± 18.0

CON
%SAT
0 2Hb, AU
Hbrox, AU

73.3 ±2.3
74.4 ± 11.3
101.3
± 13.9

63.3 ±3.7
68.5 ±6.5
108.7
± 14.5

70.3 ± 14.5
95.1
± 17.5

Values are means ± SD. *Significant (P < 0.05) difference from Pre.
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5A

5B

5C

5D

Figure 5. Ensemble-averaged [HHb] responses of HIT group to moderate-intensity
step tests; 5A) absolute [HHb] response to LS and US transitions in double-step,
constant load tests, and 5B) relative [HHb] response to LS and US transitions in
double-step, constant load tests (data normalized to the end-exercise [HHb]); 5C)
absolute [HHb] response to SS transitions, and 5D) relative [HHb] response to SS
transitions (data normalized to the end-exercise [HHb]); open circles (O ) represent
pre-training tests, closed circles ( • ) represent post-training tests at verification.
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Figure 6. NIRS-derived [HHb] responses to moderate-intensity step tests of a single
representative subject in HIT group; 6A) pre-training [HHb] response to LS and US
transitions in double-step, constant load tests, and 6B) post-training (at verification
testing) [HHb] response to LS and US transitions in double-step, constant load tests;
6C) pre-training [HHb] response to SS transition, and 6D) post-training (at
verification testing) [HHb] response to SS transition.
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A[HHb] /A VO2 ratio

Figure 7 illustrates changes in the HIT group SS mean profile for A[HHb] /
A VChp ratio, at PRE and VER. Prior to training (PRE), the overall ratio from 20 to
180 s of the transition was 1.07 (significantly different from 1, P < 0.05); following
training (VER), the ratio was no longer different from 1. Similarly, Figure 8 shows
the HIT group LS and US mean profiles for A[HHb] / AVO2 ratio. At PRE, LS and
US A[HHb] / A VChp ratios were 1.05 and 1.08, respectively (both significantly
different from 1, P < 0.05); by MID this “overshoot” was no longer apparent in either
the LS or US (i.e. the ratio was no longer different from 1). These ratios remained at
~1 throughout the remainder of the study (MID to VER).
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Figure 7. Left panel: HIT group mean profiles for adjustments of [HHb] and VCLp(left-shifted to exclude phase I VChP) in the initial 180 s of SS moderate-intensity
exercise transitions, shown for pre-training and post-training (at verification testing).
Closed circles ( • ) represent time points at which the relative increase in [HHb] is
greater than the relative increase of VC>2P. Right panel: HIT group mean profiles for
the relative adjustment of [HHb] /V 0 2 P in the initial 180 s of SS moderate-intensity
exercise transitions, shown for pre-training and post-training (at verification testing).
*Significant difference of overall A[HHb] /A V02P (20 to 180 s) from 1.0 (P < 0.05).
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Figure 8. Left panel: HIT group mean profiles for adjustments of [HHb] and VChp.
(left-shifted to exclude phase I VChp) in the initial 180 s of LS and US moderateintensity exercise transitions, shown for pre-training and post-training (at verification
testing). Adjustments shown for 8A) LS in double-step, constant load tests, and 7B)
US in double-step, constant load tests. Closed circles ( • ) represent time points at
which the relative increase in [HHb] is greater than the relative increase of VChp.
Right panel: HIT group mean profiles for the relative adjustment of [HHb] / VChP in
the initial 180 s of LS and US moderate-intensity exercise transitions, shown for pre
training and post-training (at verification testing). Adjustments shown for 7A) LS in
double-step, constant load tests, and 8B) US in double-step, constant load tests.
*Significant difference of overall A[HHb] /A VChp (20 to 180 s) from 1.0 ( P < 0.05).
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2.4 Discussion
This study investigated the effects of 12 sessions of high-intensity interval
training (HIT) on phase II pulmonary O2 uptake (VChp) and muscle deoxygenation
([HHb]) kinetics during transitions to constant-load, moderate intensity (MOD)
exercise initiated from a lower (LS) and higher (US) baseline metabolic rate. In
agreement with previous reports (10, 33, 41, 55), we observed that for similar
increments in work rate (WR), there was a slower adjustment of both V02P an [HHb]
in the US compared to the LS, as well as a greater steady-state O2 cost of exercise
(gain, AV 0 2 P/AWR) in the US, reflecting lower metabolic efficiency. As
hypothesized, there was a significant speeding of VLhp kinetics in both the LS and
US following 4 weeks (i.e., 12 sessions) of HIT training. The absolute reduction of
x V02P in the US (~20 s) was greater than that seen in the LS (~10 s); however, these
changes represented a similar relative speeding in both steps (~40%). Despite the
training-induced speeding of VChp, muscle deoxygenation ([HHb]; reflecting
fractional O2 extraction and the ratio of microvascular blood flow-to-muscle O2
utilization) kinetics did not change. These findings agree with those of McKay et al.
(43) (using a single-step MOD protocol), suggesting that the training-induced
adjustments of microvascular blood flow kinetics matched those of muscle O2
utilization. To our knowledge, this is the first study to observe training-induced
speeding of V 0 2 P kinetics initiated from a lower and higher baseline metabolic rate
within the MOD domain.
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To ensure that VChp kinetics (and other measured variables) at the
completion of HIT (POST testing) were not influenced by acute events associated
with the previous day’s HIT session, subjects completed a “verification” set of tests
(VER) at 4 days after POST testing. Prior heavy-intensity exercise has the potential to
influence motor unit’recruitment and muscle fatigue

(2 ,

thus the

15, 2 0 ),

4

days

recovery after the final HIT session and post-testing protocols confirmed that VChP
and [HHb] kinetics were not influenced by any exercise performed in the previous 12

days. The VER testing phase also confirmed training-induced improvements of

V02max and time-to-fatigue (TTF). No differences were seen in any of the variables
between POST and VER, indicating that events associated with the final HIT session
did not affect these variables at the POST testing phase.

Effectiveness o f H IT training in improving maximal VChP fVChmax), performance
A

and estimated lactate threshold (Ql)

Twelve sessions of HIT completed over a period of

4

weeks led to

improvements in VChmax and exercise performance (TTF and WRmax). These results
clearly demonstrate the effectiveness of this HIT programme in improving training
status and overall fitness. Similar improvements in these variables were reported by
McKay et al.

(4 3 ),

using a similar HIT protocol. In that study, although an increase in

absolute VChmax (L/min) did not occur, there was a small but significant increase in
the relative VChmax (from
during RI testing (from
128

308

42

to

to

46

335

ml, kg'1*min'1), as well as an increase in WRmax

W) and the WR corresponding to

0l

(from

108

to

W). In the present study, improvements in VChmax occurred from PRE to MID,
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and further from MID to POST. The greatest improvements occurred in TTF exercise
time, with an 85% increase (209 s to 386 s) from PRE to VER. Previous
investigations

have

demonstrated

the

performance

benefits

and

VChmax

improvements that accompany HIT and SIT training (3, 11-13); one particular HIT
training study (10 4-minute repeats at 90% WRmax; 3 sessions per week, 6 weeks)
observed an improvement of 111% in TTF (49).
Several physiological adaptations may contribute to the training-induced
A

improvements in exercise performance and

0l

. HIT has been shown to improve

Na+/K+ATPase activity and K+ re-uptake capacity by 15 to 20% in previously
A i

untrained individuals (see (37) for review), while sarcoplasmic reticulum (SR) Ca
re-uptake capacity is not affected. SIT has been found to induce increases in muscle
Na+/K+ATPase and Na+/H+ exchanger isoform 1 (NHE1), which are key regulators of
muscle membrane potential during exercise (34). Additionally, increases in the
expression of monocarboxylate transporter (MCT) proteins have been linked to
enhancements of muscle pH regulation; an upregulation of these proteins with HIT
may have contributed to the observed improvements in high intensity exercise
performance (TTF time, and HIT training WR) and

0 l (8 , 11, 14, 4 9 , 5 0 ).

Increases

in resting muscle glycogen and glycolytic capacity, along with decreased
glycogenolysis during exercise have also been associated with HIT, and these
adaptations may also have contributed to the increased exercise tolerance (12).
Three tests to volitional fatigue were used to establish VChma* at each testing
point: the RI, SE-105 and TTF. The RISE-105 protocol, adapted from Rossiter et al.
(53) was used to establish VChmax ? as plateaus in VOp are seldom achieved during a
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single RI exercise tests. In the present study, at each of the testing points, no
differences existed in the final VChp achieved during the RI and SE components of
the RISE-105 test or at the end of the TTF exercise test, thereby establishing a plateau
in VChp at different WRs and confirming that VChmax had been achieved.

Effect o f H I T on VChp and [ H H b ] kinetics

Single Step. Following 12 sessions of HIT, there was an overall reduction of
t VChp by -40% when the exercise transition was preformed as a single step of 20 W
to -90% 0l ; xVChp decreased from 32 s to 19 s. These improvements in xVChp
mirror those seen by McKay et al. (43), where 8 sessions of HIT (similar training
protocol) resulted in a 12 s reduction in x VChP during single-step transitions. Also, in
agreement with (43), VChP gain was not affected by training, remaining at -9-10
mL/min/W. As a consequence of similar VThP gain but faster VChp kinetics, the O2
deficit was reduced from 661 ml (PRE) to 527 ml (VER).
The CON group experienced no changes in xVChp from PRE to VER.
Although a lower steady-state baseline V02P (VChpbsi) and end-exercise VChP
( VThpss) were observed in VER compared to PRE, the overall VChp amplitude was
unchanged. The lower steady-state values in VER were not expected given that the
WRs were similar at PRE and VER, and considering that V02P amplitude and VChp
gain were similar at each time, the O2 cost and exercise efficiency likely were
unchanged. The reasons for the lower levels at VER are not known.
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Double Step. As reported previously (10, 33, 41, 55), the adjustment of VLhp
was slower and the VChp gain was greater when the exercise transition was initiated
from an elevated baseline metabolic rate (US vs LS). The HIT protocol was
associated with a speeding of VChp kinetics during transitions in both LS and US;
x VChp decreased by ~ 20 s (US) and ~ 10 s (LS).
The steady-state ratio of A[HHb]ss/A V02Pss (A[HHb]ss calculated as the
change between baseline and end-exercise) was similar between LS and US, and there
were no changes related to HIT. However, prior to the start of HIT, the normalized
A[HHb]/AVChp ratio, calculated for the first 180s of the exercise transition (44),
showed a transient overshoot relative to the steady-state value; the calculated,
“integrated” ratio (above the normalized steady-state value of 1.0) was ~1.05 (LS)
and -1.08 (US). The overshoot and calculated “integrated” ratio were not seen after 4
weeks of HIT (Figure 7).
Prior to HIT, the greater x VChp and VChp gain in the US compared to LS
were associated with a greater O2 deficit. The sum of O2 deficit in LS and US was
similar to the accumulated O2 deficit in SS. The O2 deficit in the US was reduced by
HIT, while there were no significant HIT-induced reductions in O2 deficit in the LS.
Several factors have been suggested to contribute to the slowed adjustment of
VChp in the upper region of the MOD domain: O2 availability to the working muscle
(33, 41), hierarchical recruitment of additional muscle fibres (10), intramuscular
energetic state and mitochondrial stability (9, 27, 62). In 1982, Hughson and
Morrissey (33) originally suggested that the greater x VChp in the US compared to LS
was a consequence of a slowed adjustment of bulk O2 delivery. This hypothesis was
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supported by MacPhee et al. (41), who observed slowed adjustments of femoral artery
(bulk) blood flow and O2 delivery in an US compared to a LS during knee-extension
exercise; however, recent data from Spencer et al. (55) reported similar heart rate
kinetics in LS, US and SS MOD exercise transitions, suggesting that bulk O2 delivery
likely does not play a major role in limiting MOD phase II VC)2P kinetics. Likewise,
Bowen et al. (9) observed that when exercise was initiated from an elevated baseline
metabolic rate (i.e., elevated VChp) at either a low (20 W) or higher (78 W) starting
WR, the VChp kinetics remain slowed, despite baseline elevations in muscle
oxygenation and, presumably, muscle blood flow. These observations suggest that
slowed kinetics in the upper region of the MOD domain cannot be explained by
limitations in O2 delivery alone.
Rather than a limitation in O2 delivery, specific muscle fibre recruitment and
intramuscular metabolic properties have been suggested to effect slowed VChP
kinetics of upper region MOD exercise transitions (10, 19, 20, 55). According to the
Hennemen Size Principle (32), a hierarchical recruitment of muscle fibres would
involve an initial recruitment of highly oxidative, slow twitch fibres at the onset of
lower work rates, with subsequent recruitment of less oxidative fibres as workload is
increased; the first motor units to be recruited would be expected to have a faster
adjustment of O2 uptake. Accordingly, Brittain et al. (10) hypothesized that when
exercise is initiated from a low metabolic baseline, more highly efficient muscle
fibres with fast VChp kinetics would be recruited. When exercise is initiated from an
elevated metabolic baseline, the newly recruited muscle fibres would be less efficient
and possess slower VChp kinetics. Recent findings of Bowen et al. (9) suggested that
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this was not the case, as VChp kinetics in the US were unchanged regardless of
whether the exercise was initiated from low (20 W) or high (78 W) starting WRs.
These authors suggested that the overall energetic state of the working muscle may
play an important role in determining VChp kinetics. They proposed that during
transitions from a raised metabolic rate, muscle concentration of free ADP and Pi
may be elevated, and ATP lowered compared to when exercise is started from a low
metabolic baseline (9); these changes would contribute to reductions in free energy
release from ATP hydrolysis (“less negative”

A G

a tp

),

and consequently require a

greater activation of mitochondrial oxidative energy production and muscle O2
utilization.
Muscle Deoxygenation. Despite the faster training-induced adjustments in
VChp (and muscle O2 utilization) in the LS, US and SS, no changes occurred in the
overall adjustment (TD + x) of muscle deoxygenation ([HHb]) over the course of 4
weeks HIT (or in CON). This lack of change has been also observed in previous
training studies (43, 44). There were additionally no differences observed in the
steady-state ratio of A[HHb]ss/A V02PSSbetween US and LS at any testing points, nor
were there any training-induced changes observed for this ratio. The speeding of the
VChP kinetics, without accompanying changes in the adjustment of muscle
oxygenation, suggests that micorvascular blood flow adjusted faster to accommodate
the faster rate of muscle O2 utilization following training. This is supported by the
profile of the normalized A[HHb]/AVChP ratio: during the early transition period, a
transient overshoot was seen in the ratio prior to the start of training (in both the LS
and US), but this overshoot was no longer evident following MID testing (through to
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the completion of HIT). Similar reductions in the overall normalized A[HHb]/A VChp
profile have been reported for SS transitions in response to 4 months of END training
(44).
Recently, Murias et al. (45) investigated a spectrum of values for x VChp in
young men, and concluded that VChp kinetics appeared to be constrained in part by
the matching of local microvascular O2 distribution to muscle O2 utilization. They
reported that individuals with xVThp (in SS transitions) lower than 21 s had
corresponding normalized A[HHb]/A VChp ratios of 0.98, whereas all others with
kinetics ranging 21 s to 30 s, and 31 s to 40 s had average A[HHb]/A VChP ratios of
1.05 and 1.09, respectively. In the present study, there was a similar relationship
between the “overshoot” in the normalized A[HHb]/AVChP ratio and the “slowness”
of VChp kinetics; that is, for a greater TVChp there was a greater overshoot. For
example, in the LS, average t VChp and “overshoot” were 24 s and 1.05, respectively,
whereas in the US the values were 45 s and 1.08, respectively. Given that these
“overshoot” effects were no longer present following HIT, the observed speeding of
VChp kinetics likely was due, in part, to an improved coordination of microvascular
blood flow with O2 utilization at the level of the working muscle.

Potential mechanisms contributing to speeding o f r V C hp

While prior investigations have observed the effects of HIT on VChP kinetics
in single-step MOD transitions, the current study is, to our knowledge, the first to
isolate training effects to separate lower and upper regions of the MOD domain.
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The O2 deficit provides an indication of the relative amount of energy derived
from

oxygen-independent

metabolism

(i.e.,

substrate-level

phosphorylation)

following step-increases in WR (48, 57). The O2 deficit in the SS was largely reduced
following training, however, in the separate LS and US transitions, only the O2 deficit
in the US was reduced following training, with no change in the O2 deficit of the LS.
The reduction of O2 deficit in the US from PRE to VER (120 mL) accounts for the
major part of the reduction seen in the SS (134 mL). Changes in O2 deficit during SS
suggest an overall lowered reliance on substrate-level phosphorylation at the onset of
exercise, with greater contibution from oxidative phosphorylation, which should
result in decreased PCr and glycogen degradation, lesser falls in [PCr], and a lower
accumulation of lactate" and Ef in the muscle and blood (18, 62). As the reduced O2
deficit in US appears to account for most, if not all, of the reduction in O2 deficit of
the SS, the observed speeding of VChp kinetics in the US may in part be due to a
faster activation of oxidative phosphorylation and muscle O2 utilization, with a
corresponding reduction in substrate-level phoshorylation at the active muscle sites.
While the training-induced reductions in O2 deficit provide some insight to
potential physiological adaptations of VChp in the US, the unchanged O2 deficit in
the LS perhaps prompts alternate explanations for the speeding of VChp kinetics. A
potential theory describes training-induced changes in “mitochondrial stability”;
specifically, it has been suggested that increases in mitochondrial content and
“parallel activation” (improved matching of ATP production and ATP consumption
pathways) result in a speeding of VChP kinetics, and improved exercise tolerance
following training (62). Studies using HIT (or SIT) support the idea of improved
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parallel activation: increases in citrate synthase (CS), resting muscle glycogen and the
active

for of the

mitochondrial

PDH

complex (and

other mitochondrial

dehydrogenases), with accompanying decreases in glycogenolysis and lactate
accumulation appear to result in a closer matching of glycogenolytic flux and
pyruvate production to pyruvate oxidation during exercise (12). These enhancements
of metabolic stability likely involve lower increases in

[A D P ], [Pi]

and

H +,

allowing

for improved exercise tolerance and mitochondrial metabolic efficiency (21, 28, 42).
These physiological adaptations, and the consequent speeding of xVChp, have been
known to occur independently of changes in O2 deficit (62). Therefore, improvements
in mitochondrial stability may play an important role in the observed speeding of
VChp kinetics in both the LS and US.
The theory of mitochondrial stability ties in closely with that of the “energetic
state” described by (9) and (27). If HIT attenuates the rises in [ADP] and [P;]
following exercise transitions, a lower buildup of ADP, Pi and other metabolites
contributing to the maintenance of AGatp would occur during the initial LS of the
double-step constant-load test. Subsequently, we would expect a greater (compared to
pre-training) AGatp at the onset of the US transition, speeding the adaptation of
VChp. Thus, improvements in the so-called “energetic state” may have potentially
contributed to the training-induced speeding of VChp kinetics in both the LS and US.
Training, in its various forms, has been known to lead to fibre type
conversions (see (16, 23) for reviews); however, given the relatively short duration of
the HIT programme (12 sessions, 4 weeks) used in the present study, a phenotypic
conversion in fibre type seems unlikely. A single session of SIT (4 repeats of 30 s
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“all-out” sprints) has been shown to immediately increase phosphorylation of targets
in the peroxisome proliferator-activated receptor-y

coactivator-la

(PGC-la)

signaling pathway (26). PGC-la is a key regulator of mitochondrial biogenesis, and is
linked to increases in oxidative enzyme expression (51); increases in the protein
levels of PG C-la have been observed following 6 weeks of SIT (13). The expression
of PG C-la is notably higher in muscles with greater type 1 fibre composition, and
increases in PGC-la subsequently lead to increased expression of genes that are
highly expressed in type 1 fibres, including myoglobin and troponin I (39). A
functional conversion of muscle fibres towards a more oxidative state has been
observed in PGC-la transgenic mice (39). Thus, it is possible that HIT induced
increases in PGC-la expression, leading to a shift in the metabolic profile of the
active muscle fibres. Increases in MCT protein levels have also were associated with
training (8, 11, 49, 50); MCT 1 is highly correlated to the percentage of type I
oxidative fibres in the active muscle, and it has been postulated that the increase in
this protein following training might indicate changes in fibre type (7). These
observations collectively suggest that an effective HIT programme, such as that in the
present study, may effect a shift in the metabolic properties of the muscle, and this
shift of the muscle fibres (including those potentially “less efficient” fibres thought to
be recruited in the US) towards a more oxidative state may have played a significant
role in the speeding of US VChp kinetics.
In summary, the results of the present study demonstrate a speeding of VChp
kinetics in the lower an upper regions of the MOD exercise domain, without changes
in muscle deoxygenation, following a 12 session (4 week) HIT programme. While the
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relative speeding of the LS and US did not differ, the absolute speeding of the US
doubled that of the LS following the training programme. Speeding of VChp kinetics
in both the US and LS occurred without parallel changes in the adjustment of muscle
deoxygenation; these results indicate a role for improved coordination of
microvascular blood flow with O2 utilization in the speeding of both US and LS
V02P kinetics. While the specific physiological mechanisms controlling the
adjustment of O2 uptake for each of the lower and upper regions of the MOD exercise
domain remain elusive, a prominent body of evidence suggests that training-induced
improvements in xV02P for LS and US transitions may involve metabolic
remodeling of the active muscle.
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